BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 28441138)

  • 1. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.
    Masemann D; Boergeling Y; Ludwig S
    Biol Chem; 2017 Jul; 398(8):891-909. PubMed ID: 28441138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
    Park GT; Choi KC
    Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of combinatorial strategies in the development of RNA oncolytic virus therapies.
    Nguyen TL; Tumilasci VF; Singhroy D; Arguello M; Hiscott J
    Cell Microbiol; 2009 Jun; 11(6):889-97. PubMed ID: 19388908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of virotherapy for effective tumor treatment.
    Garcia-Aragoncillo E; Hernandez-Alcoceba R
    Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New perspectives in cancer virotherapy: bringing the immune system into play.
    Boisgerault N; Tangy F; Gregoire M
    Immunotherapy; 2010 Mar; 2(2):185-99. PubMed ID: 20635927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Virotherapy and the Tumor Microenvironment.
    Berkey SE; Thorne SH; Bartlett DL
    Adv Exp Med Biol; 2017; 1036():157-172. PubMed ID: 29275471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Going viral: a review of replication-selective oncolytic adenoviruses.
    Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
    Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
    Kim J; Hall RR; Lesniak MS; Ahmed AU
    Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic virotherapy.
    Cervantes-García D; Ortiz-López R; Mayek-Pérez N; Rojas-Martínez A
    Ann Hepatol; 2008; 7(1):34-45. PubMed ID: 18376364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic viruses in the treatment of cancer: a review of current strategies.
    Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
    Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy: Challenges and solutions.
    Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
    Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic viral therapies - the clinical experience.
    Aghi M; Martuza RL
    Oncogene; 2005 Nov; 24(52):7802-16. PubMed ID: 16299539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer.
    Rao MFS; Ahmed B; Qadir MI
    Crit Rev Eukaryot Gene Expr; 2024; 34(1):1-13. PubMed ID: 37824388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
    Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy.
    Lal G; Rajala MS
    Cancer Gene Ther; 2018 Oct; 25(9-10):216-226. PubMed ID: 29735993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.